The Valley Desk

ArticleCancer innovationPublished

A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cancer innovation
Published
Subject terms
Safety; Prognosis; Biomarkers; Efficacy evaluation; Tnbc; Icis
PubMed ID
38089401
PubMed Central ID
PMC10686160
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal